These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8660828)

  • 1. T cells with two Tcrbeta chains and reactivity to both MHC/idiotypic peptide and superantigen.
    Munthe LA; Blichfeldt E; Sollien A; Dembic Z; Bogen B
    Cell Immunol; 1996 Jun; 170(2):283-90. PubMed ID: 8660828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor.
    Blichfeldt E; Munthe LA; Røtnes JS; Bogen B
    Eur J Immunol; 1996 Dec; 26(12):2876-84. PubMed ID: 8977280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two separate mechanisms of T cell clonal anergy to Mls-1.
    Yui K; Ishida Y; Katsumata M; Komori S; Chused TM; Abe R
    J Immunol; 1993 Dec; 151(11):6062-75. PubMed ID: 8245451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of V beta 6+ T cells in Mls-1a mice. A role for the third complementarity-determining region (CDR3) of the T cell receptor beta chain in superantigen recognition.
    Chies JA; Marodon G; Joret AM; Regnault A; Lembezat MP; Rocha B; Freitas AA
    J Immunol; 1995 Nov; 155(9):4171-8. PubMed ID: 7594572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor alpha-chain influences reactivity to Mls-1 in V beta 8.1 transgenic mice.
    Smith HP; Le P; Woodland DL; Blackman MA
    J Immunol; 1992 Aug; 149(3):887-96. PubMed ID: 1321853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the T cell receptor alpha-chain on T cell reactivity and tolerance to Mls-1 in T cell receptor beta-chain transgenic mice.
    Blackman MA; Smith HP; Le P; Woodland DL
    J Immunol; 1993 Jul; 151(2):556-65. PubMed ID: 8335899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR transgenic mice in which usage of transgenic alpha- and beta-chains is highly dependent on the level of selecting ligand.
    Kersh GJ; Donermeyer DL; Frederick KE; White JM; Hsu BL; Allen PM
    J Immunol; 1998 Jul; 161(2):585-93. PubMed ID: 9670931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naive CD4+ T cells confer idiotype-specific tumor resistance in the absence of antibodies.
    Bogen B; Munthe L; Sollien A; Hofgaard P; Omholt H; Dagnaes F; Dembic Z; Lauritzsen GF
    Eur J Immunol; 1995 Nov; 25(11):3079-86. PubMed ID: 7489746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation and function of mouse T-cells with a transgenic TCR positively selected by highly disparate xenogeneic porcine MHC.
    Zhao Y; Rodriguez-Barbosa JI; Zhao G; Shaffer J; Arn JS; Sykes M
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):217-28. PubMed ID: 11292257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC bias of Mls-1 recognition is not influenced by thymic positive selection.
    Nguyen P; Woodland DL; Blackman MA
    Cell Immunol; 1996 Feb; 167(2):224-9. PubMed ID: 8603431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model.
    Tamura T; Ariga H; Kinashi T; Uehara S; Kikuchi T; Nakada M; Tokunaga T; Xu W; Kariyone A; Saito T; Kitamura T; Maxwell G; Takaki S; Takatsu K
    Int Immunol; 2004 Dec; 16(12):1691-9. PubMed ID: 15477229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC class II A alpha and E alpha molecules determine the clonal deletion of V beta 6+ T cells. Studies with recombinant and transgenic mice.
    Anderson GD; Banerjee S; David CS
    J Immunol; 1989 Dec; 143(11):3757-61. PubMed ID: 2531186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of murine T cell responses to peptides of the variable region of self T cell receptor beta-chains.
    MacNeil D; Fraga E; Singh B
    J Immunol; 1993 Oct; 151(8):4045-54. PubMed ID: 8409384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
    Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
    Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
    Chen FL; Kung JT
    J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
    Nakajima H; Leonard WJ
    J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved amino acid residues in the complementarity-determining region 1 of the TCR beta-chain are involved in the recognition of conventional Ag and Mls-1 superantigen.
    Kang J; Chambers CA; Pawling J; Scott C; Hozumi N
    J Immunol; 1994 Jun; 152(11):5305-17. PubMed ID: 8189048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
    Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
    Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.